FASTINOV took part in the Luz Saúde International Congress, an event addressing infection control, antimicrobial resistance and the clinical need for faster susceptibility results.
Earlier information for better decisions
The congress provided a setting to discuss the relationship between laboratory turnaround time and clinical decision-making. FASTINOV presented ultra-rapid AST as a way to shorten the interval between a positive result and susceptibility information that can support targeted therapy.
Working across the care pathway
Conversations at the event connected laboratory diagnostics with the wider hospital response to infection. They highlighted that faster testing must be paired with clear workflows, communication between teams and appropriate clinical interpretation.
The Luz Saúde congress highlighted the importance of faster, clinically relevant susceptibility information in the response to infection.